JK
Insider
John W Kozarich
DirectorJohn W Kozarich (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Ligand Pharmaceuticals Incorporated (LGND). The largest single filing was $455K of LGND (2,034 sh across 2 lots, as filed), executed May 12.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$455K
shares × price, as filed
Last traded
May 13
Filed May 14
Median ADV $104.4M across their filed names
Open performance→Volume by month
Buys $0
Sells $572K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
LGNDRecent filings
LGNDSALE
Ligand Pharmaceuticals Incorporated
View filing →
$455K2,034 sh across 2 lots
Exec May 12
Filed May 14 · 5:30 PM ET LGNDSALE Ligand Pharmaceuticals Incorporated View filing → $117K
934 sh × $125.00
Exec Jul 10 2025
Filed Jul 11 2025 · 5:30 PM ET